- LG Electronics appoint new EA MD as it seeks larger pie in the region
- Nigeria 2023 election: Naira scarcity and the eNaira adoption may be interconnected
- Chinese phone-maker OPPO launches Reno8 T in Kenya
- Tanzania and Morocco to finalize deal on a fertilizer facility
- Infrastructure, road projects in Kenya make progress in six months
- Kenya Power prepares for electric vehicle demand
- IFC Offers ACEP Burkina $2Mn Facility to Support Farmers and SMEs in Burkina Faso
- How to Find Love Hobbies on the Ideal Dating Websites
mRNA-1644 utilizes Moderna’s messenger RNA (mRNA) technology to deliver a specific class of B cells needed to develop broadly neutralizing antibodies (bnAbs) to fight HIV infection. Inducing bnAbs is considered the primary goal of an HIV vaccine, and this requires B-cell activation.
The primary trial endpoints are safety and immunogenicity. The IAVI-sponsored clinical trial, IAVI G003, will test the safety and efficacy of vaccination with the HIV immunogen eOD-GT8 60mer, delivered via Moderna’s mRNA platform. eOD-GT8 60mer was developed by IAVI and Scripps Research teams and was initially tested in phase 1 clinical trial IAVI G001.
According to Contagion Live, IAVI G003 is expected to enroll 18 healthy, HIV-negative adults. The participants will receive 2 doses of eOD-GT8 60mer mRNA, which contains a portion of the viral sequence but cannot cause HIV infection. They will be monitored for safety for 6 months after their second dose, and their immune responses …
Stavros Nicolaou, a Senior Executive at Aspen Pharmacare Group said in the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products.
“The continent would lose its only existing COVID vaccine manufacturing capacity, It would be a massive setback for Africa’s plans to localize and reduce its dependency on imported vaccines,” he said.
John Nkengasong, director of the Africa Centres for Disease Control and Prevention, said global health security would be undermined if companies like Aspen were not backed.…
- A sense of well-being encompasses a wide range of factors, including access to education and employment, as well as the lack of armed combat or threats
- Digitization has provided a cheap, secure source of finance to populations in need and improved government transparency in countries where graft and corruption are a huge concern.
- Technological change has also resulted in increased productivity which has in turn improved African’s standards of living
When we think about the quality of life, the first thing that comes to mind is the degree to which an individual is healthy, comfortable, and able to participate in or enjoy life events.
A sense of well-being encompasses a wide range of factors, including access to education and employment, as well as the lack of armed combat or threats.
It is also relative, subjective and has intangible components, such as spiritual beliefs and a sense of belonging.
Getting treatment in Kenya’s medical institutions is akin to signing up for an expensive loan that may not be easy to service.
For instance, people who have opted to go to India say that the costs in the Asian nation are twice or thrice cheaper for the medical part. They thus opt to raise funds for the airfare and get the treatment outside Kenya.
Getting treatment in Kenya is financially draining since the National Health Insurance Fund is largely unreliable. The national scheme is the biggest insurer covering more than 90 per cent of the about eight million Kenyans with health insurance.
This means that no matter what kind of illness, the patient has to dig into their pockets despite the cover.…
Ending LF Elephantiasis as a public health problem in the three nations would make them the first cluster of countries in Africa to achieve the breakthrough.
This, following the announcement by the World Health Organisation (WHO) in January 2020 that Malawi had eliminated the disease as the second country in Africa, after Togo in 2017.
Elephantiasis is a Neglected Tropical Disease (NTD) which causes swelling and disfigurement and has left thousands of East Africans permanently disabled.…
- Africa’s death rates from COVID-19 infections are significantly higher in patients with diabetes
- The disease causes inflammation and poor blood circulation, both of which increase the risk of complications, including death, from COVID-19
- In addition to people with diabetes, the three most frequent underlying conditions included patients with HIV and hypertension
New data indicates that Africa’s sharp increase in diabetes is clashing with the COVID-19 pandemic and poor access to vaccines.
Africa’s death rates from COVID-19 infections are significantly higher in patients with diabetes, according to a preliminary analysis which the World Health Organization (WHO) presented today in advance of the World Diabetes Day on 14 November.
Dr Matshidiso Moeti, WHO Regional Director for Africa said the COVID-19 pandemic will eventually subside, but Africa is projected in the coming years to experience the highest increase in diabetes globally.
“We must act now to prevent new cases, vaccinate people who have …
In the past decade, Kenya has made tremendous advancements in increasing access to modern methods of contraception.
However, this has significantly reduced in the past year and experts are linking this downward trajectory to the recent global pandemic.
“In Kenya, contraceptives use among women of reproductive health has been on an upward trajectory from 37.2 percent in 2017/18 to 44 percent in 2019/2020. This rate has declined to 29.6% in 2020/21, due to disruption caused by the Covid-19 pandemic.(KHIS, 2021),” said Dr. Patrick Amoth the chairperson of the World Health Organisation (WHO) executive board.
Data from the Ministry of Health shows that the percentage of married women using modern methods of family planning has increased from 36% in 2007 to 61% currently. This has helped curb rapid population growth and drive development.
“With the COVID-19 pandemic upending lives across the world, …
This is the message being emphasised by Africa Centres for Disease Control and Prevention (Africa CDC) as the world pushes for continuous usage of masks in a bid to stop the spread of COVID-19.
“As the pandemic continues to spread, we must fight against pandemic fatigue and continue masking to protect our friends, our families, our communities, and the world,” reads a statement from Africa CDC.
According to the World Health Organisation (WHO) every three weeks, the new Delta variant cases keep doubling. This is not a good sign. WHO data shows that a third wave has now been reported in 16 countries. This includes nine countries that are currently experiencing surging cases.
The World Health Organisation has classified each emerging variant as either a Variant of Concern (VOC) or a Variant of Interest (VOI). The Alpha, Beta, Gamma and Delta variants fall under Variants of Concern. Whereas the Eta, …
Johnson & Johnson has recalled five of its aerosol sunscreen products.
The firm announced on Wednesday that it would like to voluntarily recall all lots of five EUTROGENA® and AVEENO® aerosol sunscreen product lines to the consumer level.
“Internal testing identified low levels of benzene in some samples of the products. Consumers should stop using the affected products and follow the instructions set forth below.” The healthcare giant said in a statement.
What Benzene really is
According to an information kit from the Center for Disease Control and Prevention (CDC), benzene is a chemical that is a colourless or light yellow liquid at room temperature. It has a sweet odour and is highly flammable.
CDC says that direct exposure of the eyes, skin, or lungs to benzene could cause tissue injury and irritation however, presenting with these signs and symptoms does not necessarily mean that a person has …
Tuberculosis and Malaria have been a thorn in the flesh of the country’s health sector.
This is why Amref Health Africa in Kenya has signed a Global Fund Tuberculosis and Malaria grant of Ksh 7.6 billion ($70,416,010).
The fund will be split into two portions: towards control of TB a total of (KES 5.6 billion) ($51,875,868) has been set aside, and to control Malaria (KES 1.8 billion) ($16,674,386) has been earmarked.
According to information from Amref, this is a 3-year project that is set to be implemented between the year 2021 and 2024 with the help of implementing partners.
Kenya’s ministry of health says that TB remains a global and national public health concern. Globally, 104 million people are infected with TB of which nearly 1.5 million die each year. In Kenya, TB is the fifth leading cause of death. In 2019, Kenya reported and treated 86,504 cases of TB …